ARCHIVES

ODAC Recommendation for Pertuzumab Signals FDA’s Resolve In Granting Accelerated Approvals

This article is from The Cancer Letter archive.

Vol. 39 No. 35 | September 20, 2013

Download PDF Visit The Full Archive

Related Articles

J&J Withdraws Power Morcellators, Citing Risk of Disseminating Cancer

August 1, 2014

IMRT Less Toxic Than 3D-CRT In Localized Prostate Cancer

October 28, 2011

NCI to Advise Women in 40s o Ask Doctor About Mammography, End Routine Screening

September 24, 1993

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

In Brief: Congress Finished Spending Bill, Reagan Signs It; NCI Gets $1.402 Billion, a $174.5 Million Raise

October 24, 1986

NCI To Establish New Offices for Special Populations, Survivorship, Klausner Tells House appropirations Subcommittee

May 3, 1996